Auris Medical Announces Initiation of Part B of TRAVERS Phase 2 Study with AM-125 in Vertigo Nasdaq:EARS
October 13, 2020 09:00 ET | Source: Auris Medical AG
Hamilton, Bermuda, October 13, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing...